Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

New treatments for PCOS focus on managing symptoms and improving fertility.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.